Antios Therapeutics

This clinical-stage biopharmaceutical entity focuses on the creation of innovative therapies for viral diseases. With a commitment to addressing unmet medical needs, it is at the forefront of developing solutions for conditions such as Hepatitis B and other viral infections. The company's approach combines scientific rigor with a patient-centric philosophy.